Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

HER2-positive Breast Cancer 1

Interventions

Standard of Care 177 Blood Specimen Collection 137 Exercise 122 Educational Status 114 Methods 108 Interviews as Topic 106 Surveys and Questionnaires 105 Practice Guidelines as Topic 105 Early Intervention, Educational 93 Magnetic Resonance Spectroscopy 79 Specimen Handling 78 Radiosurgery 68 Radiotherapy 56 Palliative Care 48 Biopsy 40 Patient Navigation 37 Control Groups 34 Resistance Training 33 Therapeutics 32 Drug Therapy 32 Surgical Procedures, Operative 31 Diet Therapy 30 Counseling 29 Behavior Therapy 29 Proton Therapy 25 Acupuncture Therapy 25 Nutrition Assessment 24 Exercise Test 24 Magnetic Resonance Imaging 23 Radiation 22

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Phase NA × Isovaleryl-CoA Dehydrogenase × 1 year × Clear all

NCT07281001 2025-12-15

Traderrus

Blokhin's Russian Cancer Research Center

Phase NA Recruiting

HER2-positive Breast Cancer

Data powered by HemOnc (CC BY 4.0) Colophon ⚡